Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly

被引:10
作者
Martin-Rodriguez, Juan F. [1 ,2 ]
Munoz-Bravo, Jose L. [1 ,2 ]
Ibanez-Costa, Alejandro [3 ,4 ,5 ]
Fernandez-Maza, Laura [6 ]
Balcerzyk, Marcin [6 ]
Leal-Campanario, Roco [7 ]
Luque, Raul M. [3 ,4 ,5 ]
Castano, Justo P. [3 ,4 ,5 ]
Venegas-Moreno, Eva [1 ,2 ]
Soto-Moreno, Alfonso [1 ,2 ]
Leal-Cerro, Alfonso [2 ]
Cano, David A. [1 ,2 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Gest Clin Endocrinol & Nutr, Seville, Spain
[2] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, IBiS, Seville, Spain
[3] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Cordoba 14014, Spain
[4] CIBER Fisiopatol Obesidad & Nutr, Cordoba 14014, Spain
[5] Campus Excelencia Int Agroalimentario ceiA3, Cordoba 14014, Spain
[6] Univ Seville, CSIC, Ctr Nacl Aceleradores, Seville, Spain
[7] Univ Pablo de Olavide, Div Neurociencias, Seville, Spain
关键词
POSITRON-EMISSION-TOMOGRAPHY; SOMATOSTATIN RECEPTOR SUBTYPE-1; GENE-EXPRESSION LEVELS; PITUITARY-ADENOMAS; IN-VIVO; QUANTITATIVE-ANALYSIS; DOPAMINE AGONISTS; FREE CALCIUM; E-CADHERIN; OCTREOTIDE;
D O I
10.1038/srep16298
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acromegaly is a disorder resulting from excessive production of growth hormone (GH) and consequent increase of insulin-like growth factor 1 (IGF-I), most frequently caused by pituitary adenomas. Elevated GH and IGF-I levels results in wide range of somatic, cardiovascular, endocrine, metabolic, and gastrointestinal morbidities. Subcutaneous implantation of the GH-secreting GC cell line in rats leads to the formation of tumors. GC tumor-bearing rats develop characteristics that resemble human acromegaly including gigantism and visceromegaly. However, GC tumors remain poorly characterized at a molecular level. In the present work, we report a detailed histological and molecular characterization of GC tumors using immunohistochemistry, molecular biology and imaging techniques. GC tumors display histopathological and molecular features of human GH-producing tumors, including hormone production, cell architecture, senescence activation and alterations in cell cycle gene expression. Furthermore, GC tumors cells displayed sensitivity to somatostatin analogues, drugs that are currently used in the treatment of human GH-producing adenomas, thus supporting the GC tumor model as a translational tool to evaluate therapeutic agents. The information obtained would help to maximize the usefulness of the GC rat model for research and preclinical studies in GH-secreting tumors.
引用
收藏
页数:15
相关论文
共 68 条
[1]  
Asa SL, 2011, ATLAS TUMOR PATHOLOG
[2]   The Pathogenesis of Pituitary Tumors [J].
Asa, Sylvia L. ;
Ezzat, Shereen .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :97-126
[3]   Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas [J].
Bamberger, CM ;
Fehn, M ;
Bamberger, AM ;
Lüdecke, DK ;
Beil, FU ;
Saeger, W ;
Schulte, HM .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (03) :250-255
[4]   Pituitary somatostatin receptor signaling [J].
Ben-Shlomo, Anat ;
Melmed, Shlomo .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2010, 21 (03) :123-133
[5]   CHRONIC GROWTH-HORMONE (GH) HYPERSECRETION INDUCES RECIPROCAL AND REVERSIBLE CHANGES IN MESSENGER-RNA LEVELS FROM HYPOTHALAMIC GH-RELEASING HORMONE AND SOMATOSTATIN NEURONS IN THE RAT [J].
BERTHERAT, J ;
TIMSIT, J ;
BLUETPAJOT, MT ;
MERCADIER, JJ ;
GOURDJI, D ;
KORDON, C ;
EPELBAUM, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1783-1791
[6]   SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile [J].
Bruns, C ;
Lewis, I ;
Briner, U ;
Meno-Tetang, G ;
Weckbecker, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (05) :707-716
[7]   Genetically engineered mouse models of pituitary tumors [J].
Cano, David A. ;
Soto-Moreno, Alfonso ;
Leal-Cerro, Alfonso .
FRONTIERS IN ONCOLOGY, 2014, 4 :1-30
[8]   Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide [J].
Casar-Borota, Olivera ;
Heck, Ansgar ;
Schulz, Stefan ;
Nesland, Jahn Marthin ;
Ramm-Pettersen, Jon ;
Lekva, Tove ;
Alafuzoff, Irina ;
Bollerslev, Jens .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11) :E1730-E1739
[9]   Biological activity of somatostatin receptors in GC rat tumour somatotrophs:: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists [J].
Cervia, D ;
Zizzari, P ;
Pavan, B ;
Schuepbach, E ;
Langenegger, D ;
Hoyer, D ;
Biondi, C ;
Epelbaum, J ;
Bagnoli, P .
NEUROPHARMACOLOGY, 2003, 44 (05) :672-685
[10]   Inhibitory control of growth hormone secretion by somatostatin in rat pituitary GC cells:: sst2 but not sst1 receptors are coupled to inhibition of single-cell intracellular free calcium concentrations [J].
Cervia, D ;
Petrucci, C ;
Bluet-Pajot, MT ;
Epelbaum, J ;
Bagnoli, P .
NEUROENDOCRINOLOGY, 2002, 76 (02) :99-110